Ercc1 and other markers for stratification of non-small cell lung cancer patients
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- NANTOMICS LLC
- Publication Date
- 2019-06-04
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
[0001] This application claims priority to U.S. Provisional Application Serial No. 62 / 311368, filed March 21, 2016, and also claims priority to U.S. Provisional Application Serial No. 62 / 337209, filed May 16, 2016; both provisional Both applications are incorporated herein by reference. technical field
[0002] The field of the invention is systems and methods for correlating selected markers with clinical outcomes, particularly with regard to non-small cell lung cancer and ERCC1 status and recurrence-free survival / overall survival. Background technique
[0003] The Background Description includes information useful in understanding the present invention. It is not an admission that any information provided herein is prior art or relevant to the presently claimed invention, or that any publication specifically or implicitly referenced is prior art.
[0004] All publications and patent applications are herein incorporated by reference as if each individual publication or pat...